Needham & Company LLC Reiterates Hold Rating for Mazor Robotics Ltd. (MZOR)
Mazor Robotics Ltd. (NASDAQ:MZOR)‘s stock had its “hold” rating restated by investment analysts at Needham & Company LLC in a research note issued on Wednesday.
MZOR has been the subject of a number of other reports. Zacks Investment Research cut Mazor Robotics from a “buy” rating to a “hold” rating in a report on Wednesday, September 14th. Barclays PLC upped their price objective on Mazor Robotics from $24.00 to $28.00 and gave the stock an “overweight” rating in a report on Tuesday. Standpoint Research began coverage on Mazor Robotics in a report on Friday, July 8th. They issued a “buy” rating and a $30.00 price objective for the company. Finally, B. Riley began coverage on Mazor Robotics in a research note on Tuesday. They issued a “neutral” rating and a $25.00 target price for the company. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $26.25.
Shares of Mazor Robotics (NASDAQ:MZOR) opened at 24.06 on Wednesday. The company’s 50-day moving average price is $23.38 and its 200 day moving average price is $18.27. Mazor Robotics has a 1-year low of $8.31 and a 1-year high of $26.55. The firm’s market cap is $521.45 million.
Mazor Robotics (NASDAQ:MZOR) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. Mazor Robotics had a negative return on equity of 42.30% and a negative net margin of 60.75%. The firm earned $8.30 million during the quarter, compared to analysts’ expectations of $8.51 million. During the same period in the prior year, the business earned ($0.05) EPS. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, analysts predict that Mazor Robotics will post ($0.71) EPS for the current year.
A number of large investors have recently bought and sold shares of MZOR. EAM Investors LLC acquired a new stake in Mazor Robotics during the second quarter worth approximately $2,348,000. Iguana Healthcare Management LLC raised its position in shares of Mazor Robotics by 384.6% in the first quarter. Iguana Healthcare Management LLC now owns 121,151 shares of the company’s stock worth $1,507,000 after buying an additional 96,151 shares during the last quarter. Menta Capital LLC raised its position in shares of Mazor Robotics by 81.9% in the first quarter. Menta Capital LLC now owns 37,482 shares of the company’s stock worth $466,000 after buying an additional 16,879 shares during the last quarter. Candriam Luxembourg S.C.A. purchased a new position in shares of Mazor Robotics during the second quarter worth $1,079,000. Finally, Cookson Peirce & Co. Inc. purchased a new position in shares of Mazor Robotics during the second quarter worth $192,000. 18.71% of the stock is currently owned by institutional investors and hedge funds.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.